Raymond J. Bartoszek
Director, Proteostasis Therapeutics (United States).
Companies
- Proteostasis Therapeutics (United States)Board member Dec 20, 2022 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Proteostasis Therapeutics (United States)0 shares2Jun 30, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 30, 2025Returned to company 1,000 shares of Proteostasis Therapeutics (United States)2
- Jun 30, 2025Returned to company 1,001 shares of Proteostasis Therapeutics (United States)2
- Jun 30, 2025Returned to company 1,748,473 shares of Proteostasis Therapeutics (United States)2
- Jun 30, 2025Returned to company 31,000 shares of Proteostasis Therapeutics (United States)2
- Jun 25, 2025Granted 6,000 shares of Proteostasis Therapeutics (United States)3
- Jun 23, 2025Shares withheld for tax 4,706 shares at $0.26 of Proteostasis Therapeutics (United States)3
- Jun 23, 2025Exercised options 12,500 shares at $0.61 of Proteostasis Therapeutics (United States)3
- May 1, 2024Other 903,995 shares at $0.55 of Proteostasis Therapeutics (United States)4
- Dec 6, 2023Bought 250 shares at $4.50 of Proteostasis Therapeutics (United States)5
- Dec 5, 2023Bought 1,000 shares at $4.50 of Proteostasis Therapeutics (United States)5
- Dec 4, 2023Bought 1,000 shares at $4.33 of Proteostasis Therapeutics (United States)5
- Sep 19, 2023Bought 2,000 shares at $2.37 of Proteostasis Therapeutics (United States)6
- Sep 18, 2023Bought 2,500 shares at $2.08 of Proteostasis Therapeutics (United States)7
- Sep 15, 2023Bought 500 shares at $2.18 of Proteostasis Therapeutics (United States)7
- Jun 14, 2023Exercised options 60,018 shares at $0.14 of Proteostasis Therapeutics (United States)8
- Dec 30, 2022Bought 1,000 shares at $6.23 of Proteostasis Therapeutics (United States)9
- Dec 30, 2022Bought 1,001 shares at $6.23 of Proteostasis Therapeutics (United States)9
- Dec 30, 2022Bought 5,000 shares at $6.23 of Proteostasis Therapeutics (United States)9
- Dec 16, 2022Granted 860 shares of Proteostasis Therapeutics (United States)10
- Dec 16, 2022Granted 4,096 shares of Proteostasis Therapeutics (United States)10
- Dec 16, 2022Granted 375,757 shares at $11.55 of Proteostasis Therapeutics (United States)10
- Dec 16, 2022Granted 347,118 shares of Proteostasis Therapeutics (United States)10
- Dec 16, 2022Granted 61,585 shares of Proteostasis Therapeutics (United States)10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Jun 25, 2025
- 4SEC EDGARForm 4 filed May 2, 2024
- 5SEC EDGARForm 4 filed Dec 6, 2023
- 6SEC EDGARForm 4 filed Sep 21, 2023
- 7SEC EDGARForm 4 filed Sep 19, 2023
- 8SEC EDGARForm 4 filed Jun 16, 2023
- 9SEC EDGARForm 4 filed Jan 4, 2023
- 10SEC EDGARForm 4 filed Dec 20, 2022